Shinichiro Kurosawa, M.D., Ph.D.
Dr. Kurosawa’s laboratory strives to bring new therapeutics and novel diagnostics to patients using in vitro approaches, and model systems including pre-clinical models of diseases. A significant portion of his effort is committed to translational medicine especially in the field of sepsis, inflammation, thrombosis and hemostasis. The laboratory focuses on studying the host response to microbial components by the establishment, standardization and validation of animal models. Most recently, they have applied high throughput technology to evaluate host responses at molecular level.